Response to COVID-19 Vaccination in Patients with Inflammatory Bowel Disease on Biological Treatment

Response to COVID-19 Vaccination in Patients with Inflammatory Bowel Disease on Biological Treatment

<b>Background:</b> The antibody response to coronavirus disease 2019 (COVID-19) vaccination in patients with inflammatory bowel disease (IBD) on biological drugs is still unclear. <b>Aim:</b> To determine the anti-SARS-CoV-2 spike 1 (anti-S1-IgG) response rate and antibody le...

Full description

Bibliographic Details
Main Authors: Giorgia Bodini, Elisabetta Giuliana, Irene Giberti, Giulia Guarona, Federica Benvenuto, Elisa Ferretti, Maria Giulia Demarzo, Giorgio Da Rin, Giancarlo Icardi, Edoardo G. Giannini
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Gastrointestinal Disorders
Subjects:
ulcerative colitis
Crohn’s disease
anti-SARS-CoV-2 antibodies
anti-TNF
prophylaxis
Online Access:https://www.mdpi.com/2624-5647/4/2/9

Internet

https://www.mdpi.com/2624-5647/4/2/9

Similar Items